User profiles for Matthias Cavassini
Matthias CavassiniHead of the Infectious Diseases outpatient clinic, CHUV, Lausanne, Switzerland Verified email at chuv.ch Cited by 31013 |
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
P Thoueille, E Choong, M Cavassini… - Journal of …, 2022 - academic.oup.com
The long-acting antiretroviral cabotegravir and rilpivirine combination has just received FDA,
EMA and Health Canada approval. This novel drug delivery approach is about to …
EMA and Health Canada approval. This novel drug delivery approach is about to …
[HTML][HTML] Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
…, S Patterson, S Grabar, C Cazanave, M Cavassini… - The lancet HIV, 2017 - thelancet.com
Background Health care for people living with HIV has improved substantially in the past
two decades. Robust estimates of how these improvements have affected prognosis and life …
two decades. Robust estimates of how these improvements have affected prognosis and life …
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
S Simioni, M Cavassini, JM Annoni, AR Abraham… - Aids, 2010 - journals.lww.com
Objective: To determine the prevalence of cognitive complaints and HIV-associated
neurocognitive disorders (HANDs) in a cohort of aviremic HIV-positive patients. To evaluate the …
neurocognitive disorders (HANDs) in a cohort of aviremic HIV-positive patients. To evaluate the …
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
…, M Battegay, B Hirschel, M Cavassini… - Clinical infectious …, 2011 - academic.oup.com
(See the Editorial Commentary by Saag, on pages 1140–2 .) Background. Patterns of morbidity
and mortality among human immunodeficiency virus (HIV)–infected individuals taking …
and mortality among human immunodeficiency virus (HIV)–infected individuals taking …
Dominant TNF-α+Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease
…, M Perreau, JM Stalder, LP Nicod, M Cavassini… - Nature medicine, 2011 - nature.com
Rapid diagnosis of active Mycobacterium tuberculosis (Mtb) infection remains a clinical and
laboratory challenge. We have analyzed the cytokine profile (interferon-γ (IFN-γ), tumor …
laboratory challenge. We have analyzed the cytokine profile (interferon-γ (IFN-γ), tumor …
PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
The mechanisms responsible for the persistence of HIV-1 after many years of suppressive
antiretroviral therapy (ART) have been only partially elucidated. Most of the studies …
antiretroviral therapy (ART) have been only partially elucidated. Most of the studies …
Characteristics, Determinants, and clinical relevance of CD4 T cell recovery to< 500 cells/µL in HIV type 1—infected individuals receiving potent antiretroviral therapy
…, M Opravil, P Vernazza, M Cavassini… - Clinical infectious …, 2005 - academic.oup.com
Background . The CD4 T cell count recovery in human immunodeficiency virus type 1 (HIV-1)—infected
individuals receiving potent antiretroviral therapy (ART) shows high variability. …
individuals receiving potent antiretroviral therapy (ART) shows high variability. …
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
…, L Elzi, B Hirschel, M Cavassini… - Clinical Infectious …, 2007 - academic.oup.com
Background . Human immunodeficiency virus (HIV)–infected persons may be at increased
risk for developing type 2 diabetes mellitus because of viral coinfection and adverse effects of …
risk for developing type 2 diabetes mellitus because of viral coinfection and adverse effects of …
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised …
…, E Koenig, R Elion, M Cavassini… - The Lancet Infectious …, 2016 - thelancet.com
Background Antiretroviral regimens containing tenofovir disoproxil fumarate have been
associated with renal toxicity and reduced bone mineral density. Tenofovir alafenamide is a …
associated with renal toxicity and reduced bone mineral density. Tenofovir alafenamide is a …
Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better
KEA Darling, A Hachfeld, M Cavassini, O Kirk… - Swiss medical …, 2016 - smw.ch
Summary In 2014, there were 36.9 million people worldwide living with human immunodeficiency
virus (PLWH), of whom 17.1 million did not know they were infected. Whilst the number …
virus (PLWH), of whom 17.1 million did not know they were infected. Whilst the number …